Skip to main content

Advertisement

Table 3 Physical performance data divided in three groups according to the assigned intervention

From: Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study

Variables Exercise group Dopamine agonists group Placebo group
STS- 5 (sec)    
Baseline 10.12±2.56 8.89±0.74 9.69±0.46
6-m post 8.24±2.34† 8.48±1.72 8.81±0.66
Δ Change −1.75±2.32 - 0.41±1.63 - 0.88±0.76
95% CI of Δ change −3.03 to −0.47 −1.91 to 1.09 −1.58 to −0.18
STS-30 (rep)    
Baseline 14.73±4.00 14.83±2.13 14.75±0.9
6-m post 17.84± 4.68† 14.50±2.58 17.25±3.2
Δ Change 2.96±4.87 - 0.33±2.33 2.50±2.51
95% CI of Δ change 5.65 to 0.27 −0.63 to −0.03 4.81 to −0.19
STS-60 (rep)    
Baseline 27.95±8.38 26.60±3.64 30.0±3.16
6-m post 32.50±9.34 27.40±7.40 32.0±5.35
Δ Change 4.26±8.23 0.80±4.65 2.00±3.26
95% CI of Δ change 8.77 to −0.25 5.09 to −3.49 5.0 to −1.0
Normal Walk (sec)    
Baseline 6.09±1.24 5.69±1.53 5.30±1.06
6-m post 5.81±1.49 6.14±1.63 5.38±1.09
Δ Change −0.42±1.36 0.44±1.46 0.07±0.27
95% CI of Δ change −1.17 to 0.33 1.78 to −0.90 0.31 to −0.17
Fast Walk (sec)    
Baseline 3.86±0.66 3.57±0.40 3.77±0.47
6-m post 3.65±0.75 3.56±0.40 3.57±0.41
Δ Change −0.28±0.65 - 0.01±0.19 - 0.19±0.40
95% CI of Δ change −0.63 to 0.07 −0.18 to 0.16 −0.55 to 0.17
NSRI test (sec)    
Baseline 84.46±21.35 70.10±20.46 52.48±14.24
6-m post 75.02±26.60† 67.68±20.78 53.44±17.13
Δ Change −9.25±13.41 −2.41±6.52 0.96±4.01
95% CI of Δ change −16.6 to −1.85 −8.41 to 3.59 4.65 to −2.73
  1. All data are mean ± SD. Abbreviations: STS-5 Sit-to- stand test 5-repetitions, STS-60 Sit-to- stand test 60 seconds, STS-30 Repetitions’ measurement at 30 seconds as part of the STS-60 test, NSRI North staffordshire royal infirmary test.
  2. Significantly different from the respective baseline value.